amikacin has been researched along with Neurodegenerative Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiem, K; Hue, F; Magallon, J; Tolmasky, ME | 1 |
| Chang, Y; Jiang, X; Li, G; Ma, R; Wang, C; Wu, Y; Zheng, S; Zhu, J | 1 |
2 other study(ies) available for amikacin and Neurodegenerative Diseases
| Article | Year |
|---|---|
Inhibition of aminoglycoside 6'-N-acetyltransferase type Ib-mediated amikacin resistance by zinc complexed with clioquinol, an ionophore active against tumors and neurodegenerative diseases.
Topics: Acetyltransferases; Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Clioquinol; Drug Resistance, Bacterial; Ionophores; Microbial Sensitivity Tests; Neurodegenerative Diseases; Zinc | 2018 |
AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; AMP-Activated Protein Kinases; Animals; Disease Models, Animal; Memory Disorders; Mice; Mice, Transgenic; Mitochondrial Dynamics; Neurodegenerative Diseases; tau Proteins; Tauopathies | 2023 |